Positive Clinical Breast Cancer Data Presented for NuView’s Molecular…
Next generation PET imaging agent identifies 100% of malignant breast cancer tumors in clinical trial and displays potential to replace many invasive biopsy procedures.(PRWeb March 13, 2013)Read the full story at http://www.prweb.com/releases/2013/3…
Positive Clinical Breast Cancer Data Presented for NuView’s Molecular… Read Post »
